Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Abvc Biopharma (ABVC) over the last 12 years, with Q3 2025 value amounting to -$118586.0.

  • Abvc Biopharma's Non Operating Income rose 3581.62% to -$118586.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$475957.0, marking a year-over-year increase of 1871.42%. This contributed to the annual value of -$664334.0 for FY2024, which is 4719.56% up from last year.
  • According to the latest figures from Q3 2025, Abvc Biopharma's Non Operating Income is -$118586.0, which was up 3581.62% from -$14223.0 recorded in Q2 2025.
  • Abvc Biopharma's Non Operating Income's 5-year high stood at $682196.0 during Q4 2021, with a 5-year trough of -$1.2 million in Q3 2023.
  • Its 5-year average for Non Operating Income is -$112451.4, with a median of -$77005.0 in 2021.
  • Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 43290.85% in 2021, then crashed by 12244788.73% in 2022.
  • Over the past 5 years, Abvc Biopharma's Non Operating Income (Quarter) stood at $682196.0 in 2021, then crashed by 134.23% to -$233488.0 in 2022, then skyrocketed by 94.36% to -$13164.0 in 2023, then plummeted by 598.59% to -$91963.0 in 2024, then dropped by 28.95% to -$118586.0 in 2025.
  • Its last three reported values are -$118586.0 in Q3 2025, -$14223.0 for Q2 2025, and -$251185.0 during Q1 2025.